Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-07-02 Option Award |
2021-07-07 4:05 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | WEISS FRED G Director |
61,188 | $0 | 123,972 (Direct) |
View |
2021-06-18 Tax Withholding |
2021-06-22 4:06 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | WEISS FRED G Director |
18,584 | $2.89 | 62,784 (Direct) |
View |
2021-06-18 Tax Withholding |
2021-06-22 4:05 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | COWAN GREGORY L Director |
18,584 | $2.89 | 55,561 (Direct) |
View |
2021-05-18 Tax Withholding |
2021-05-20 4:07 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | Schaub James EVP and COO |
6,621 | $3.12 | 312,100 (Direct) |
View |
2021-05-18 Tax Withholding |
2021-05-20 4:06 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | Klein Christopher General Counsel & Secretary |
6,467 | $3.12 | 211,362 (Direct) |
View |
2021-05-18 Tax Withholding |
2021-05-20 4:06 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | Einhorn Andrew J. Chief Financial Officer |
6,467 | $3.12 | 173,932 (Direct) |
View |
2021-05-18 Tax Withholding |
2021-05-20 4:05 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | deVries Tina Marie EVP, Research & Development |
6,467 | $3.12 | 151,195 (Direct) |
View |
2021-01-24 Tax Withholding |
2021-01-26 7:03 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | Schaub James EVP and COO |
9,687 | $4.46 | 318,721 (Direct) |
View |
2021-01-24 Tax Withholding |
2021-01-26 7:03 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | Klein Christopher General Counsel & Secretary |
9,605 | $4.46 | 217,829 (Direct) |
View |
2021-01-24 Tax Withholding |
2021-01-26 7:02 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | Einhorn Andrew J. Chief Financial Officer |
9,668 | $4.46 | 180,399 (Direct) |
View |
2021-01-24 Tax Withholding |
2021-01-26 7:01 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | deVries Tina Marie EVP, Research & Development |
9,597 | $4.46 | 157,662 (Direct) |
View |
2021-01-24 Tax Withholding |
2021-01-26 7:01 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | WEISS FRED G Director |
5,505 | $4.46 | 81,368 (Direct) |
View |
2021-01-24 Tax Withholding |
2021-01-26 7:00 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | COWAN GREGORY L Director |
5,505 | $4.46 | 74,145 (Direct) |
View |
2020-11-20 Other |
2020-11-23 5:13 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | Venkataraman Sriram Director 10% Owner |
4,936,926 | $0 | 21,700,785 (Indirect) |
View |
2020-11-20 Other |
2020-11-23 5:11 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | Burgstahler David F Director 10% Owner |
4,936,926 | $0 | 21,700,785 (Indirect) |
View |
2020-11-20 Other |
2020-11-23 5:10 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | Avista Capital Partners III GP L.P. Avista Healthcare Partners GP Ltd. Avista Healthcare Partners L.P. Orbit Co-Invest III LLC 10% Owner |
4,936,926 | $0 | 21,700,785 (Indirect) |
View |
2020-05-20 Option Award |
2020-05-22 4:27 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | COWAN GREGORY L Director |
38,716 | $0 | 79,650 (Direct) |
View |
2020-05-21 Tax Withholding |
2020-05-22 4:27 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | COWAN GREGORY L Director |
11,112 | $4.6 | 79,650 (Direct) |
View |
2020-05-20 Option Award |
2020-05-22 4:27 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | WEISS FRED G Director |
38,716 | $0 | 86,873 (Direct) |
View |
2020-05-21 Tax Withholding |
2020-05-22 4:27 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | WEISS FRED G Director |
17,778 | $4.6 | 86,873 (Direct) |
View |
2020-05-20 Option Award |
2020-05-22 4:26 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | MARKISON BRIAN A Chief Executive Officer |
249,787 | $0 | 2,375,807 (Direct) |
View |
2020-05-18 Option Award |
2020-05-20 9:49 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | Klein Christopher General Counsel and Secretary |
71,550 | $0 | 298,984 (Direct) |
View |
2020-05-18 Option Award |
2020-05-20 9:48 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | Einhorn Andrew J. Chief Financial Officer |
71,550 | $0 | 261,617 (Direct) |
View |
2020-05-18 Option Award |
2020-05-20 9:48 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | deVries Tina Marie EVP, Research & Development |
71,550 | $0 | 238,809 (Direct) |
View |
2020-05-18 Option Award |
2020-05-20 9:47 pm |
N/A N/A |
Osmotica Pharmaceuticals plc | OSMT | Schaub James EVP and COO |
73,253 | $0 | 401,661 (Direct) |
View |